Theravance Biopharma, Inc. Share Price
NASDAQ: TBPHHealthcare
Live Theravance Biopharma, Inc. Share Price Chart
O H L
Theravance Biopharma, Inc. Performance Overview
Days Range
▼
$17.03Low
$17.04High
Markets Today
| Previous Close | $17.04 |
|---|---|
| Open | $17.03 |
| Volume | 63,939 |
| Day's Range | $17.03 - $17.04 |
| 52W Range | $13.08 - $21.03 |
| Market Cap | $884.18 M |
Historical Performance
| 1M Returns | +0.53 |
|---|---|
| 3M Returns | +2.77 |
| 6M Returns | +23.21 |
| 1Y Returns | +17.76 |
| 5Y Returns | +139.66 |
| 10Y Returns | -49.39 |
Theravance Biopharma, Inc. Fundamentals
| Market Cap | $884.18 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 16.89 |
| PEG Ratio | N/A |
| Revenue | $107.46 M |
| ROE TTM | 0.45 |
| EPS TTM | $1.01 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.05 |
| EBITDA | $-1.98 M |
| Profit Margin | 98.54 |
| Market Cap | $884.18 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 16.89 |
| PEG Ratio | N/A |
| Revenue | $107.46 M |
| ROE TTM | 0.45 |
| EPS TTM | $1.01 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.05 |
| EBITDA | $-1.98 M |
| Profit Margin | 98.54 |
Theravance Biopharma, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $15.39 M | $26.20 M | $19.99 M | $45.89 M | $17.70 M | $20.73 M |
| Gross Profit + | $15.39 M | $26.20 M | $19.99 M | $45.89 M | $17.70 M | $20.73 M |
| Operating Income | -$14.43 M | -$2.73 M | -$6.46 M | $20.01 M | -$9.48 M | -$8.28 M |
| EBITDA | -$14.02 M | -$3.06 M | -$6.05 M | $20.41 M | -$5.47 M | -$5.42 M |
| Interest Expense | -$643.00 K | -$663.00 K | -$573.00 K | -$582.00 K | $0 | $0 |
| Depreciation | $413.00 K | -$340.00 K | $405.00 K | $399.00 K | $4.01 M | $2.86 M |
| Income Before Tax | -$14.14 M | $73.21 M | -$2.89 M | $73.07 M | -$6.47 M | -$4.79 M |
| Income Tax Expense | -$559.00 K | $18.37 M | -$6.50 M | $12.04 M | -$1.54 M | $1.11 M |
| Net Income + | -$13.58 M | $54.84 M | $3.62 M | $61.02 M | -$4.93 M | -$5.90 M |
| Net Profit Margin | -88.24% | 209.33% | 18.08% | 132.98% | -27.87% | -28.45% |
Theravance Biopharma, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K |
| Reserve & Surplus | -$979.10 M | -$924.28 M | -$920.62 M | -$859.57 M | -$864.62 M | -$870.53 M |
| Non-Current Liabilities | $146.10 M | $146.55 M | $145.37 M | $150.54 M | $149.94 M | $149.30 M |
| Current Liabilities | $31.50 M | $54.63 M | $37.41 M | $71.10 M | $64.57 M | $63.56 M |
| Total Liabilities | $177.60 M | $201.19 M | $182.78 M | $188.85 M | $181.72 M | $180.06 M |
| Fixed Assets | $7.03 M | $6.64 M | $6.26 M | $5.89 M | $5.54 M | $5.17 M |
| Current Assets | $150.26 M | $366.29 M | $354.70 M | $418.46 M | $417.63 M | $416.66 M |
| Total Assets | $343.58 M | $426.04 M | $415.46 M | $485.57 M | $472.31 M | $469.77 M |
Theravance Biopharma, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$13.58 M | $54.84 M | $3.62 M | $61.02 M | -$4.93 M | -$5.90 M |
| Operating Cash Flow | $43.04 M | $208.07 M | -$6.51 M | -$6.06 M | $73.28 M | -$6.96 M |
| Investing Cash Flow | $30.63 M | -$36.26 M | -$100.25 M | $588.00 K | $52.59 M | -$60.40 M |
| Financing Cash Flow | -$854.00 K | -$503.00 K | -$400.00 K | -$1.49 M | -$5.58 M | -$967.00 K |
| Change in Cash | $72.82 M | $171.31 M | -$107.15 M | -$6.97 M | $120.30 M | -$68.33 M |
Theravance Biopharma, Inc. Return Calculator
The Theravance Biopharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$23,952
Invested Amount$10,000
Est. Returns$13,952
About Theravance Biopharma, Inc.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Popular Stocks
FAQs
What is the share price of Theravance Biopharma, Inc. today?
Theravance Biopharma, Inc. (TBPH) share price as of September 18, 2026 is $17.03. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Theravance Biopharma, Inc.?
Yes, Indian Investors can invest in the Theravance Biopharma, Inc. (TBPH) Share by opening an international trading account with Angel One.
How can I purchase Theravance Biopharma, Inc. shares in India?
Purchasing Theravance Biopharma, Inc. (TBPH) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Theravance Biopharma, Inc. (TBPH) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Theravance Biopharma, Inc.?
Yes, you can purchase fractional shares of Theravance Biopharma, Inc. (TBPH) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Theravance Biopharma, Inc.?
The market capitalization of Theravance Biopharma, Inc. on September 18, 2026, is $884.18 M.
In which sector Theravance Biopharma, Inc. belongs?
Theravance Biopharma, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Theravance Biopharma, Inc. stocks?
In order to invest in Theravance Biopharma, Inc. (TBPH) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
